Biomaterial Database

Fibrocystic breast disease. 1987

E B Scott

University of Pittsburgh School of Medicine, Pennsylvania.

Fibrocystic breast disease is characterized by breast pain, lumpiness or cysts. The few patients who have atypia on breast biopsy are at substantially increased risk for the development of breast cancer. Management of fibrocystic breast disease involves monitoring for breast cancer by repeated physical and mammographic examinations. Alleviation of symptoms may be attempted by reassurance, reduction of methylxanthine intake and treatment with danazol.

UI	MeSH Term	Description	Entries
D008327	Mammography	Radiographic examination of the breast.	3D-Mammography,Digital Breast Tomosynthesis,Digital Mammography,X-ray Breast Tomosynthesis,3D Mammography,3D-Mammographies,Breast Tomosyntheses, Digital,Breast Tomosyntheses, X-ray,Breast Tomosynthesis, Digital,Breast Tomosynthesis, X-ray,Digital Breast Tomosyntheses,Digital Mammographies,Mammographies,Mammographies, Digital,Mammography, Digital,X ray Breast Tomosynthesis,X-ray Breast Tomosyntheses
D008875	Middle Aged	An adult aged 45 - 64 years.	Middle Age
D009747	Nutritional Physiological Phenomena	The processes and properties of living organisms by which they take in and balance the use of nutritive materials for energy, heat production, or building material for the growth, maintenance, or repair of tissues and the nutritive properties of FOOD.	Nutrition Physiological Phenomena,Nutrition Physiology,Nutrition Processes,Nutritional Physiology Phenomena,Nutrition Phenomena,Nutrition Physiological Concepts,Nutrition Physiological Phenomenon,Nutrition Process,Nutritional Phenomena,Nutritional Physiological Phenomenon,Nutritional Physiology,Nutritional Physiology Concepts,Nutritional Physiology Phenomenon,Nutritional Process,Nutritional Processes,Concept, Nutrition Physiological,Concept, Nutritional Physiology,Concepts, Nutrition Physiological,Concepts, Nutritional Physiology,Nutrition Physiological Concept,Nutritional Physiology Concept,Phenomena, Nutrition,Phenomena, Nutrition Physiological,Phenomena, Nutritional,Phenomena, Nutritional Physiological,Phenomena, Nutritional Physiology,Phenomenon, Nutrition Physiological,Phenomenon, Nutritional Physiological,Phenomenon, Nutritional Physiology,Physiological Concept, Nutrition,Physiological Concepts, Nutrition,Physiological Phenomena, Nutrition,Physiological Phenomena, Nutritional,Physiological Phenomenon, Nutrition,Physiological Phenomenon, Nutritional,Physiology Concept, Nutritional,Physiology Concepts, Nutritional,Physiology Phenomena, Nutritional,Physiology Phenomenon, Nutritional,Physiology, Nutrition,Physiology, Nutritional,Process, Nutrition,Process, Nutritional,Processes, Nutrition,Processes, Nutritional
D010173	Palpation	Application of fingers with light pressure to the surface of the body to determine consistence of parts beneath in physical diagnosis; includes palpation for determining the outlines of organs.	Palpations
D001940	Breast	In humans, one of the paired regions in the anterior portion of the THORAX. The breasts consist of the MAMMARY GLANDS, the SKIN, the MUSCLES, the ADIPOSE TISSUE, and the CONNECTIVE TISSUES.	Breasts
D001971	Bromocriptine	A semisynthetic ergotamine alkaloid that is a dopamine D2 agonist. It suppresses prolactin secretion.	2-Bromoergocryptine,Bromocryptin,2-Bromo-alpha-ergocryptine,2-Bromo-alpha-ergokryptine,2-Bromoergocryptine Mesylate,2-Bromoergocryptine Methanesulfonate,2-Bromoergokryptine,Bromocriptin,Bromocriptine Mesylate,CB-154,Parlodel,2 Bromo alpha ergocryptine,2 Bromo alpha ergokryptine,2 Bromoergocryptine,2 Bromoergocryptine Mesylate,2 Bromoergocryptine Methanesulfonate,2 Bromoergokryptine,CB 154,CB154,Mesylate, 2-Bromoergocryptine,Mesylate, Bromocriptine,Methanesulfonate, 2-Bromoergocryptine
D003613	Danazol	A synthetic steroid with antigonadotropic and anti-estrogenic activities that acts as an anterior pituitary suppressant by inhibiting the pituitary output of gonadotropins. It possesses some androgenic properties. Danazol has been used in the treatment of endometriosis and some benign breast disorders.	Azol,Cyclomen,Danatrol,Danazant,Danazol-Ratiopharm,Danocrine,Danol,Danoval,Ladogal,Norciden,Panacrine,Danazol Ratiopharm
D005260	Female		Females
D005348	Fibrocystic Breast Disease	A common and benign breast disease characterized by varying degree of fibrocystic changes in the breast tissue. There are three major patterns of morphological changes, including FIBROSIS, formation of CYSTS, and proliferation of glandular tissue (adenosis). The fibrocystic breast has a dense irregular, lumpy, bumpy consistency.	Breast Dysplasia,Fibrocystic Mastopathy,Mammary Dysplasia,Adenosis of Breast,Chronic Cystic Mastitis,Cystic Breast Disease,Cystic Disease of Breast,Fibrocystic Changes of Breast,Fibrocystic Disease of Breast,Microglandular Adenosis,Adenoses, Microglandular,Adenosis, Microglandular,Breast Adenosis,Breast Cystic Disease,Breast Cystic Diseases,Breast Disease, Cystic,Breast Disease, Fibrocystic,Breast Fibrocystic Change,Breast Fibrocystic Changes,Breast Fibrocystic Disease,Cystic Mastitis, Chronic,Disease, Cystic Breast,Disease, Fibrocystic Breast,Dysplasia, Breast,Dysplasia, Mammary,Mastopathy, Fibrocystic,Microglandular Adenoses
D006801	Humans	Members of the species Homo sapiens.	Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man